MyoKardia, Inc. Common Stock
MYOK
MYOK was delisted on the 16th of November, 2020.
235 hedge funds and large institutions have $5.32B invested in MyoKardia, Inc. Common Stock in 2020 Q2 according to their latest regulatory filings, with 69 funds opening new positions, 98 increasing their positions, 51 reducing their positions, and 27 closing their positions.
156% more first-time investments, than exits
New positions opened: 69 | Existing positions closed: 27
131% more capital invested
Capital invested by funds: $2.3B → $5.32B (+$3.02B)
92% more repeat investments, than reductions
Existing positions increased: 98 | Existing positions reduced: 51
63% more funds holding in top 10
Funds holding in top 10: 8 → 13 (+5)
21% more funds holding
Funds holding: 194 → 235 (+41)
34% less call options, than puts
Call options by funds: $31.8M | Put options by funds: $48.6M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BBA
Baker Bros. Advisors
New York
|
+$116M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
+$77.8M |
| 3 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$54.8M |
| 4 |
Invesco
Atlanta,
Georgia
|
+$46M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$44.4M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
-$42M |
| 2 |
Janus Henderson Group
London,
|
-$28.5M |
| 3 |
HA
HHLR Advisors
Grand Cayman,
Cayman Islands
|
-$23.8M |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$20M |
| 5 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
-$18.1M |
MYOK Hedge Fund Activity: Q2 2020 in Review
235 of the 4,888 institutional investors tracked by Wall St. Rank reported a position in MyoKardia, Inc. Common Stock (MYOK) for Q2 2020, worth a combined $5.32B — up 131% from $2.3B a quarter earlier.
Buyers outnumbered sellers: 69 funds opened new MYOK positions and 27 closed out — a net gain of 42 holders — while 98 added to existing stakes and 51 trimmed.
The largest buyer was Baker Bros. Advisors, adding an estimated $116M. The largest seller was Wellington Management Group, cutting an estimated $42M.
- 235 institutional investors held MyoKardia, Inc. Common Stock (MYOK) as of Q2 2020, up from 194 in Q1 2020.
- Funds reported $5.32B of MyoKardia, Inc. Common Stock stock for Q2 2020, up 131% quarter-over-quarter.
- 69 funds opened new MyoKardia, Inc. Common Stock positions in Q2 2020 and 27 closed out, a net change of +42 holders.
- The largest MyoKardia, Inc. Common Stock buyer in Q2 2020 was Baker Bros. Advisors, an estimated $116M added.
- The largest MyoKardia, Inc. Common Stock seller in Q2 2020 was Wellington Management Group, an estimated $42M sold.
Based on aggregated 13F filings for Q2 2020.